| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d77e120d1588e76c73afc1a3197a126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b338af7adeed5220d7db2826672e2b1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_218debc45969aa2940dd86103892c0b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b9dda98fc484b59854d9041357ed359
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2d8ee8a7ec53c9ca54aeb731fc3e438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4923d7b49f496f8a19b260a345d8d5af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af2df347f020e813e3f8bb62ef8b0d66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ceeb7a577e04589223ee3feda8fa090
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b783bf182e6dea33e3a1cc5e86a95aed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee160e73b1bcd7b4f98c60e48459441
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a77c249f83e1b4ca4e8a6bece293d24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2db3710b9857b294b1ce0e61eb847ad7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_496d5387225f6bd5f2720280820c4c71 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-08 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2011-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_784c5daa1af1de69f0763a8664848f81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24965e6c72216eb979bed813a4e3e5f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52091ce91e0fdf57e1f67f47a09b0de6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b497efaba281aac08eb525dda76dc13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04f9e4e5294b92fcbe49c3a288068434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0dca0164cff3b7f15a2255ed73f791f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abb1bfa57306d950f7cb91cb25494599
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86479d68b6d14193443083d79ae1342b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3128dbcd2a7bfd22606b4b35a13b3c9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04db77c421f028ebe808204855ca5aa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7891b7f38018a8449a6d1254077c5f35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dd8586e012db5820c6f60cea82a84ab |
| publicationDate |
2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013149376-A1 |
| titleOfInvention |
Vaccine composition based on sticholysin encapsulated into liposomes |
| abstract |
The current invention relates to the field of Biotechnology applied to human health. Here it is described a vaccine vehicle wherein toxins from eukaryotic organisms are encapsulated into multilamellar vesicles obtained by the dehydration-rehydration procedure whose lipidic composition is dipalmitoylphosphatidylcholine:cholesterol in a 1:1 molar ratio for subcutaneous or intramuscular administration. These compositions do not require the use of other adjuvants. n The disclosed compositions allow modulation of CTL-specific immune response against one or several antigens co-encapsulated into toxin-containing liposomes. The vaccinal vehicle of the present invention shows advantages over others disclosed by the previous art due to the robustness and functionality of the induced immune response as well as its immunomodulating properties. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9717687-B2 |
| priorityDate |
2010-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |